Jaffer A Ajani (Jaffer Ajani)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 76

Top Venues

The Journal of experimental medicine

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Cancer discovery

British journal of cancer

UT M. D. Anderson Cancer Center

This page only lists publications with an associated author ORCID identifier.

Affiliation History

UT M. D. Anderson Cancer Center Jul 01 1980

United States

Professor :: GI Medical Oncology

Publications

Yelena Y Janjigian, Jaffer A Ajani, Markus Möhler, Lin Shen, Marcelo Garrido, Carlos Gallardo, Lucjan Wyrwicz, Kensei Yamaguchi, James M Cleary, Elena Elimova, Michalis V Karamouzis, Ricardo Bruges, Tomasz Skoczylas, Arinilda Bragagnoli, Tianshi Liu, Mustapha Tehfé, Thomas Zander, Ruben Kowalyszyn, Roberto A Pazo-Cid, Michael Schenker, Kynan Feeny, Rui Wang, Ming Lei, Clara Chen, Raheel Nathani, Kohei Shitara
First-Line Nivolumab Plus Chemotherapy for Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: 3-Year Follow-Up of the Phase III CheckMate 649 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Yelena Y Janjigian, Jaffer A Ajani, Markus Möhler, Lin Shen, Marcelo Garrido, Carlos Gallardo, Lucjan Wyrwicz, Kensei Yamaguchi, James M Cleary, Elena Elimova, Michalis V Karamouzis, Ricardo Bruges, Tomasz Skoczylas, Arinilda Bragagnoli, Tianshi Liu, Mustapha Tehfé, Thomas Zander, Ruben Kowalyszyn, Roberto A Pazo-Cid, Michael Schenker, Kynan Feeny, Rui Wang, Ming Lei, Clara Chen, Raheel Nathani, Kohei Shitara
First-Line Nivolumab Plus Chemotherapy for Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: 3-Year Follow-Up of the Phase III CheckMate 649 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (17) (2024)
Yelena Y Janjigian, Jaffer A Ajani, Markus Möhler, Lin Shen, Marcelo Garrido, Carlos Gallardo, Lucjan Wyrwicz, Kensei Yamaguchi, James M Cleary, Elena Elimova, Michalis V Karamouzis, Ricardo Bruges, Tomasz Skoczylas, Arinilda Bragagnoli, Tianshi Liu, Mustapha Tehfé, Thomas Zander, Ruben Kowalyszyn, Roberto A Pazo-Cid, Michael Schenker, Kynan Feeny, Rui Wang, Ming Lei, Clara Chen, Raheel Nathani, Kohei Shitara
First-Line Nivolumab Plus Chemotherapy for Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: 3-Year Follow-Up of the Phase III CheckMate 649 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (17) (2024)
Gengyi Zou, Yuanjian Huang, Shengzhe Zhang, Kyung-Phil Ko, Bongjun Kim, Jie Zhang, Vishwa Venkatesan, Melissa P Pizzi, Yibo Fan, Sohee Jun, Na Niu, Huamin Wang, Shumei Song, Jaffer A Ajani, Jae-Il Park
E-cadherin loss drives diffuse-type gastric tumorigenesis via EZH2-mediated reprogramming. The Journal of experimental medicine 221 (4) (2024)
Yoshihiro Hara, Yoshifumi Baba, Eri Oda, Kazuto Harada, Kohei Yamashita, Tasuku Toihata, Keisuke Kosumi, Masaaki Iwatsuki, Yuji Miyamoto, Hiroyasu Tsutsuki, Qiong Gan, Rebecca E Waters, Yoshihiro Komohara, Tomohiro Sawa, Jaffer A Ajani, Hideo Baba
Presence of Fusobacterium nucleatum in relation to patient survival and an acidic environment in oesophagogastric junction and gastric cancers. British journal of cancer (2024)
Ken Kato, Yuichiro Doki, Ian Chau, Jianming Xu, Lucjan Wyrwicz, Satoru Motoyama, Takashi Ogata, Hisato Kawakami, Chih-Hung Hsu, Antoine Adenis, Farid El Hajbi, Maria Di Bartolomeo, Maria Ignez Braghiroli, Eva Holtved, Tomoki Makino, Mariela Blum Murphy, Carlos Amaya-Chanaga, Apurva Patel, Nan Hu, Yasuhiro Matsumura, Yuko Kitagawa, Jaffer A Ajani
Nivolumab plus chemotherapy or ipilimumab versus chemotherapy in patients with advanced esophageal squamous cell carcinoma (CheckMate 648): 29-month follow-up from a randomized, open-label, phase III trial. Cancer medicine 13 (9) (2024)
Ken Kato, Yuichiro Doki, Ian Chau, Jianming Xu, Lucjan Wyrwicz, Satoru Motoyama, Takashi Ogata, Hisato Kawakami, Chih-Hung Hsu, Antoine Adenis, Farid El Hajbi, Maria Di Bartolomeo, Maria Ignez Braghiroli, Eva Holtved, Tomoki Makino, Mariela Blum Murphy, Carlos Amaya-Chanaga, Apurva Patel, Nan Hu, Yasuhiro Matsumura, Yuko Kitagawa, Jaffer A Ajani
Nivolumab plus chemotherapy or ipilimumab versus chemotherapy in patients with advanced esophageal squamous cell carcinoma (CheckMate 648): 29-month follow-up from a randomized, open-label, phase III trial. Cancer medicine 13 (9) (2024)
Ken Kato, Yuichiro Doki, Ian Chau, Jianming Xu, Lucjan Wyrwicz, Satoru Motoyama, Takashi Ogata, Hisato Kawakami, Chih-Hung Hsu, Antoine Adenis, Farid El Hajbi, Maria Di Bartolomeo, Maria Ignez Braghiroli, Eva Holtved, Tomoki Makino, Mariela Blum Murphy, Carlos Amaya-Chanaga, Apurva Patel, Nan Hu, Yasuhiro Matsumura, Yuko Kitagawa, Jaffer A Ajani
Nivolumab plus chemotherapy or ipilimumab versus chemotherapy in patients with advanced esophageal squamous cell carcinoma (CheckMate 648): 29-month follow-up from a randomized, open-label, phase III trial. Cancer medicine 13 (9) (2024)
Juhyung Park, Jibo Wu, Krzysztof J Szkop, Jinho Jeong, Predrag Jovanovic, Dylan Husmann, Natasha M Flores, Joel W Francis, Ying-Jiun C Chen, Ana Morales Benitez, Emily Zahn, Shumei Song, Jaffer A Ajani, Linghua Wang, Kamini Singh, Ola Larsson, Benjamin A Garcia, Ivan Topisirovic, Or Gozani, Pawel K Mazur
SMYD5 methylation of rpL40 links ribosomal output to gastric cancer. Nature 632 (8025) (2024)
Gengyi Zou, Yuanjian Huang, Shengzhe Zhang, Kyung-Phil Ko, Bongjun Kim, Jie Zhang, Vishwa Venkatesan, Melissa P Pizzi, Yibo Fan, Sohee Jun, Na Niu, Huamin Wang, Shumei Song, Jaffer A Ajani, Jae-Il Park
E-cadherin loss drives diffuse-type gastric tumorigenesis via EZH2-mediated reprogramming. The Journal of experimental medicine 221 (4) (2024)
Sarina A Piha-Paul, Chieh Tseng, Cheuk Hong Leung, Ying Yuan, Daniel D Karp, Vivek Subbiah, David Hong, Siqing Fu, Aung Naing, Jordi Rodon, Milind Javle, Jaffer A Ajani, Kanwal P S Raghav, Neeta Somaiah, Gordon B Mills, Apostolia-Maria Tsimberidou, Xiaofeng Zheng, Ken Chen, Funda Meric-Bernstam
Phase II study of talazoparib in advanced cancers with BRCA1/2, DNA repair, and PTEN alterations. NPJ precision oncology 8 (1) (2024)
Jiahui Jiang, Yunhe Liu, Jiang-Jiang Qin, Jianfeng Chen, Jingjing Wu, Melissa P Pizzi, Rossana Lazcano, Kohei Yamashita, Zhiyuan Xu, Guangsheng Pei, Kyung Serk Cho, Yanshuo Chu, Ansam Sinjab, Fuduan Peng, Xinmiao Yan, Guangchun Han, Ruiping Wang, Enyu Dai, Yibo Dai, Bogdan A Czerniak, P Andrew Futreal, Anirban Maitra, Alexander J F Lazar, Humam Kadara, Amir A Jazaeri, Xiangdong Cheng, Jaffer A Ajani, Jianjun Gao, Jian Hu, Linghua Wang
METI: deep profiling of tumor ecosystems by integrating cell morphology and spatial transcriptomics. Nature communications 15 (1) (2024)
Timothy P DiPeri, Kurt W Evans, Bailiang Wang, Ming Zhao, Argun Akcakanat, Maria Gabriela Raso, Yasmeen Q Rizvi, Xiaofeng Zheng, Anil Korkut, Kaushik Varadarajan, Burak Uzunparmak, Ecaterina E Ileana Dumbrava, Shubham Pant, Jaffer A Ajani, Paula R Pohlmann, Vanessa B Jensen, Milind M Javle, Jordi Rodon Ahnert, Funda Meric-Bernstam
Co-clinical Trial of Novel Bispecific Anti-HER2 Antibody Zanidatamab in Patient-Derived Xenografts. Cancer discovery 14 (5) (2024)
Sarina A Piha-Paul, Binghe Xu, Ecaterina E Dumbrava, Siqing Fu, Daniel D Karp, Funda Meric-Bernstam, David S Hong, Jordi A Rodon, Apostolia M Tsimberidou, Kanwal Raghav, Jaffer A Ajani, Anthony P Conley, Frank Mott, Ying Fan, Jean Fan, Peng Peng, Hui Wang, Shumao Ni, Caixia Sun, Xiaoyan Qiang, Wendy J Levin, Brenda Ngo, Qinhua Cindy Ru, Frank Wu, Milind M Javle
First-In-Human Phase I Study of Tinengotinib (TT-00420), a Multiple Kinase Inhibitor, as a Single Agent in Patients With Advanced Solid Tumors. The oncologist 29 (4) (2024)
Timothy P DiPeri, Kurt W Evans, Bailiang Wang, Ming Zhao, Argun Akcakanat, Maria Gabriela Raso, Yasmeen Q Rizvi, Xiaofeng Zheng, Anil Korkut, Kaushik Varadarajan, Burak Uzunparmak, Ecaterina E Ileana Dumbrava, Shubham Pant, Jaffer A Ajani, Paula R Pohlmann, Vanessa B Jensen, Milind M Javle, Jordi Rodon Ahnert, Funda Meric-Bernstam
Co-clinical Trial of Novel Bispecific Anti-HER2 Antibody Zanidatamab in Patient-Derived Xenografts. Cancer discovery 14 (5) (2024)
Juhyung Park, Jibo Wu, Krzysztof J Szkop, Jinho Jeong, Predrag Jovanovic, Dylan Husmann, Natasha M Flores, Joel W Francis, Ying-Jiun C Chen, Ana Morales Benitez, Emily Zahn, Shumei Song, Jaffer A Ajani, Linghua Wang, Kamini Singh, Ola Larsson, Benjamin A Garcia, Ivan Topisirovic, Or Gozani, Pawel K Mazur
SMYD5 methylation of rpL40 links ribosomal output to gastric cancer. Nature 632 (8025) (2024)
Timothy P DiPeri, Kurt W Evans, Bailiang Wang, Ming Zhao, Argun Akcakanat, Maria Gabriela Raso, Yasmeen Q Rizvi, Xiaofeng Zheng, Anil Korkut, Kaushik Varadarajan, Burak Uzunparmak, Ecaterina E Ileana Dumbrava, Shubham Pant, Jaffer A Ajani, Paula R Pohlmann, Vanessa B Jensen, Milind M Javle, Jordi Rodon Ahnert, Funda Meric-Bernstam
Co-clinical Trial of Novel Bispecific Anti-HER2 Antibody Zanidatamab in Patient-Derived Xenografts. Cancer discovery 14 (5) (2024)
Brian D Badgwell, Naruhiko Ikoma, Mariela Blum Murphy, Xuemei Wang, Jeannelyn Estrella, Xiaoqian Liu, Jitesh Kawedia, Jenny Jing Li, Paul Mansfield, Jaffer A Ajani
Phase 1 trial of intraperitoneal paclitaxel in patients with gastric adenocarcinoma and carcinomatosis or positive cytology. Cancer (2024)
Ken Kato, Yuichiro Doki, Ian Chau, Jianming Xu, Lucjan Wyrwicz, Satoru Motoyama, Takashi Ogata, Hisato Kawakami, Chih-Hung Hsu, Antoine Adenis, Farid El Hajbi, Maria Di Bartolomeo, Maria Ignez Braghiroli, Eva Holtved, Tomoki Makino, Mariela Blum Murphy, Carlos Amaya-Chanaga, Apurva Patel, Nan Hu, Yasuhiro Matsumura, Yuko Kitagawa, Jaffer A Ajani
Nivolumab plus chemotherapy or ipilimumab versus chemotherapy in patients with advanced esophageal squamous cell carcinoma (CheckMate 648): 29-month follow-up from a randomized, open-label, phase III trial. Cancer medicine 13 (9) (2024)
Timothy P DiPeri, Kurt W Evans, Bailiang Wang, Ming Zhao, Argun Akcakanat, Maria Gabriela Raso, Yasmeen Q Rizvi, Xiaofeng Zheng, Anil Korkut, Kaushik Varadarajan, Burak Uzunparmak, Ecaterina E Ileana Dumbrava, Shubham Pant, Jaffer A Ajani, Paula R Pohlmann, Vanessa B Jensen, Milind M Javle, Jordi Rodon Ahnert, Funda Meric-Bernstam
Co-clinical Trial of Novel Bispecific Anti-HER2 Antibody Zanidatamab in Patient-Derived Xenografts. Cancer discovery 14 (5) (2024)
Yelena Y Janjigian, Jaffer A Ajani, Markus Möhler, Lin Shen, Marcelo Garrido, Carlos Gallardo, Lucjan Wyrwicz, Kensei Yamaguchi, James M Cleary, Elena Elimova, Michalis V Karamouzis, Ricardo Bruges, Tomasz Skoczylas, Arinilda Bragagnoli, Tianshi Liu, Mustapha Tehfé, Thomas Zander, Ruben Kowalyszyn, Roberto A Pazo-Cid, Michael Schenker, Kynan Feeny, Rui Wang, Ming Lei, Clara Chen, Raheel Nathani, Kohei Shitara
First-Line Nivolumab Plus Chemotherapy for Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: 3-Year Follow-Up of the Phase III CheckMate 649 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (17) (2024)
Yoshihiro Hara, Yoshifumi Baba, Eri Oda, Kazuto Harada, Kohei Yamashita, Tasuku Toihata, Keisuke Kosumi, Masaaki Iwatsuki, Yuji Miyamoto, Hiroyasu Tsutsuki, Qiong Gan, Rebecca E Waters, Yoshihiro Komohara, Tomohiro Sawa, Jaffer A Ajani, Hideo Baba
Presence of Fusobacterium nucleatum in relation to patient survival and an acidic environment in oesophagogastric junction and gastric cancers. British journal of cancer 131 (5) (2024)
Gengyi Zou, Yuanjian Huang, Shengzhe Zhang, Kyung-Phil Ko, Bongjun Kim, Jie Zhang, Vishwa Venkatesan, Melissa P Pizzi, Yibo Fan, Sohee Jun, Na Niu, Huamin Wang, Shumei Song, Jaffer A Ajani, Jae-Il Park
E-cadherin loss drives diffuse-type gastric tumorigenesis via EZH2-mediated reprogramming. The Journal of experimental medicine 221 (4) (2024)
Timothy P DiPeri, Kurt W Evans, Bailiang Wang, Ming Zhao, Argun Akcakanat, Maria Gabriela Raso, Yasmeen Q Rizvi, Xiaofeng Zheng, Anil Korkut, Kaushik Varadarajan, Burak Uzunparmak, Ecaterina E Ileana Dumbrava, Shubham Pant, Jaffer A Ajani, Paula R Pohlmann, Vanessa B Jensen, Milind M Javle, Jordi Rodon Ahnert, Funda Meric-Bernstam
Co-clinical Trial of Novel Bispecific Anti-HER2 Antibody Zanidatamab in Patient-Derived Xenografts. Cancer discovery 14 (5) (2024)
Ken Kato, Yuichiro Doki, Ian Chau, Jianming Xu, Lucjan Wyrwicz, Satoru Motoyama, Takashi Ogata, Hisato Kawakami, Chih-Hung Hsu, Antoine Adenis, Farid El Hajbi, Maria Di Bartolomeo, Maria Ignez Braghiroli, Eva Holtved, Tomoki Makino, Mariela Blum Murphy, Carlos Amaya-Chanaga, Apurva Patel, Nan Hu, Yasuhiro Matsumura, Yuko Kitagawa, Jaffer A Ajani
Nivolumab plus chemotherapy or ipilimumab versus chemotherapy in patients with advanced esophageal squamous cell carcinoma (CheckMate 648): 29-month follow-up from a randomized, open-label, phase III trial. Cancer medicine 13 (9) (2024)
Sarina A Piha-Paul, Chieh Tseng, Cheuk Hong Leung, Ying Yuan, Daniel D Karp, Vivek Subbiah, David Hong, Siqing Fu, Aung Naing, Jordi Rodon, Milind Javle, Jaffer A Ajani, Kanwal P S Raghav, Neeta Somaiah, Gordon B Mills, Apostolia-Maria Tsimberidou, Xiaofeng Zheng, Ken Chen, Funda Meric-Bernstam
Phase II study of talazoparib in advanced cancers with BRCA1/2, DNA repair, and PTEN alterations. NPJ precision oncology 8 (1) (2024)
Gengyi Zou, Yuanjian Huang, Shengzhe Zhang, Kyung-Phil Ko, Bongjun Kim, Jie Zhang, Vishwa Venkatesan, Melissa P Pizzi, Yibo Fan, Sohee Jun, Na Niu, Huamin Wang, Shumei Song, Jaffer A Ajani, Jae-Il Park
E-cadherin loss drives diffuse-type gastric tumorigenesis via EZH2-mediated reprogramming. The Journal of experimental medicine 221 (4) (2024)
Gengyi Zou, Yuanjian Huang, Shengzhe Zhang, Kyung-Phil Ko, Bongjun Kim, Jie Zhang, Vishwa Venkatesan, Melissa P Pizzi, Yibo Fan, Sohee Jun, Na Niu, Huamin Wang, Shumei Song, Jaffer A Ajani, Jae-Il Park
E-cadherin loss drives diffuse-type gastric tumorigenesis via EZH2-mediated reprogramming. The Journal of experimental medicine 221 (4) (2024)
Juhyung Park, Jibo Wu, Krzysztof J Szkop, Jinho Jeong, Predrag Jovanovic, Dylan Husmann, Natasha M Flores, Joel W Francis, Ying-Jiun C Chen, Ana Morales Benitez, Emily Zahn, Shumei Song, Jaffer A Ajani, Linghua Wang, Kamini Singh, Ola Larsson, Benjamin A Garcia, Ivan Topisirovic, Or Gozani, Pawel K Mazur
SMYD5 methylation of rpL40 links ribosomal output to gastric cancer. Nature 632 (8025) (2024)
Sarina A Piha-Paul, Chieh Tseng, Cheuk Hong Leung, Ying Yuan, Daniel D Karp, Vivek Subbiah, David Hong, Siqing Fu, Aung Naing, Jordi Rodon, Milind Javle, Jaffer A Ajani, Kanwal P S Raghav, Neeta Somaiah, Gordon B Mills, Apostolia-Maria Tsimberidou, Xiaofeng Zheng, Ken Chen, Funda Meric-Bernstam
Phase II study of talazoparib in advanced cancers with BRCA1/2, DNA repair, and PTEN alterations. NPJ precision oncology 8 (1) (2024)
Yelena Y Janjigian, Jaffer A Ajani, Markus Möhler, Lin Shen, Marcelo Garrido, Carlos Gallardo, Lucjan Wyrwicz, Kensei Yamaguchi, James M Cleary, Elena Elimova, Michalis V Karamouzis, Ricardo Bruges, Tomasz Skoczylas, Arinilda Bragagnoli, Tianshi Liu, Mustapha Tehfé, Thomas Zander, Ruben Kowalyszyn, Roberto A Pazo-Cid, Michael Schenker, Kynan Feeny, Rui Wang, Ming Lei, Clara Chen, Raheel Nathani, Kohei Shitara
First-Line Nivolumab Plus Chemotherapy for Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: 3-Year Follow-Up of the Phase III CheckMate 649 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (17) (2024)
Sarina A Piha-Paul, Binghe Xu, Ecaterina E Dumbrava, Siqing Fu, Daniel D Karp, Funda Meric-Bernstam, David S Hong, Jordi A Rodon, Apostolia M Tsimberidou, Kanwal Raghav, Jaffer A Ajani, Anthony P Conley, Frank Mott, Ying Fan, Jean Fan, Peng Peng, Hui Wang, Shumao Ni, Caixia Sun, Xiaoyan Qiang, Wendy J Levin, Brenda Ngo, Qinhua Cindy Ru, Frank Wu, Milind M Javle
First-In-Human Phase I Study of Tinengotinib (TT-00420), a Multiple Kinase Inhibitor, as a Single Agent in Patients With Advanced Solid Tumors. The oncologist (2024)
Timothy P DiPeri, Kurt W Evans, Bailiang Wang, Ming Zhao, Argun Akcakanat, Maria Gabriela Raso, Yasmeen Q Rizvi, Xiaofeng Zheng, Anil Korkut, Kaushik Varadarajan, Burak Uzunparmak, Ecaterina E Ileana Dumbrava, Shubham Pant, Jaffer A Ajani, Paula R Pohlmann, Vanessa B Jensen, Milind M Javle, Jordi Rodon Ahnert, Funda Meric-Bernstam
Co-Clinical Trial of Novel Bispecific Anti-HER2 Antibody Zanidatamab in Patient-Derived Xenografts. Cancer discovery (2024)
Jiahui Jiang, Yunhe Liu, Jiang-Jiang Qin, Jianfeng Chen, Jingjing Wu, Melissa P Pizzi, Rossana Lazcano, Kohei Yamashita, Zhiyuan Xu, Guangsheng Pei, Kyung Serk Cho, Yanshuo Chu, Ansam Sinjab, Fuduan Peng, Xinmiao Yan, Guangchun Han, Ruiping Wang, Enyu Dai, Yibo Dai, Bogdan A Czerniak, P Andrew Futreal, Anirban Maitra, Alexander J F Lazar, Humam Kadara, Amir A Jazaeri, Xiangdong Cheng, Jaffer A Ajani, Jianjun Gao, Jian Hu, Linghua Wang
METI: deep profiling of tumor ecosystems by integrating cell morphology and spatial transcriptomics. Nature communications 15 (1) (2024)
Gengyi Zou, Yuanjian Huang, Shengzhe Zhang, Kyung-Phil Ko, Bongjun Kim, Jie Zhang, Vishwa Venkatesan, Melissa P Pizzi, Yibo Fan, Sohee Jun, Na Niu, Huamin Wang, Shumei Song, Jaffer A Ajani, Jae-Il Park
E-cadherin loss drives diffuse-type gastric tumorigenesis via EZH2-mediated reprogramming. The Journal of experimental medicine 221 (4) (2024)
Yujie Jiang, Matthew D Montierth, Kaixian Yu, Shuangxi Ji, Shuai Guo, Quang Tran, Xiaoqian Liu, Seung Jun Shin, Shaolong Cao, Ruonan Li, Yuxin Tang, Tom Lesluyes, Edmund S Kopetz, Jaffer A Ajani, Pavlos Msaouel, Sumit K Subudhi, Ana Aparicio, Padmanee Sharma, John Paul Shen, Anil K Sood, Maxime Tarabichi, Jennifer R Wang, Marek Kimmel, Peter Van Loo, Hongtu Zhu, Wenyi Wang
Pan-cancer subclonal mutation analysis of 7,827 tumors predicts clinical outcome. bioRxiv : the preprint server for biology (2024)
Rebecca Waters, Matheus Sewastjanow-Silva, Kohei Yamashita, Ahmed A Abdelhakeem, Kenneth K Iwata, Diarmuid Moran, Dina Elsouda, Abraham Guerrero, Melissa Pizzi, Ernesto Rosa Vicentini, Namita Shanbhag, Anh Ta, Deyali Chatterjee, Jaffer A Ajani
Retrospective Study of Claudin 18 Isoform 2 Prevalence and Prognostic Association in Gastric and Gastroesophageal Junction Adenocarcinoma. JCO precision oncology 8 (2024)
Gengyi Zou, Yuanjian Huang, Shengzhe Zhang, Kyung-Phil Ko, Bongjun Kim, Jie Zhang, Vishwa Venkatesan, Melissa P Pizzi, Yibo Fan, Sohee Jun, Na Niu, Huamin Wang, Shumei Song, Jaffer A Ajani, Jae-Il Park
E-cadherin loss drives diffuse-type gastric tumorigenesis via EZH2-mediated reprogramming. The Journal of experimental medicine 221 (4) (2024)
Jiahui Jiang, Yunhe Liu, Jiang-Jiang Qin, Jianfeng Chen, Jingjing Wu, Melissa P Pizzi, Rossana Lazcano, Kohei Yamashita, Zhiyuan Xu, Guangsheng Pei, Kyung Serk Cho, Yanshuo Chu, Ansam Sinjab, Fuduan Peng, Xinmiao Yan, Guangchun Han, Ruiping Wang, Enyu Dai, Yibo Dai, Bogdan A Czerniak, P Andrew Futreal, Anirban Maitra, Alexander J F Lazar, Humam Kadara, Amir A Jazaeri, Xiangdong Cheng, Jaffer A Ajani, Jianjun Gao, Jian Hu, Linghua Wang
METI: deep profiling of tumor ecosystems by integrating cell morphology and spatial transcriptomics. Nature communications 15 (1) (2024)
Rebecca Waters, Matheus Sewastjanow-Silva, Kohei Yamashita, Ahmed A Abdelhakeem, Kenneth K Iwata, Diarmuid Moran, Dina Elsouda, Abraham Guerrero, Melissa Pizzi, Ernesto Rosa Vicentini, Namita Shanbhag, Anh Ta, Deyali Chatterjee, Jaffer A Ajani
Retrospective Study of Claudin 18 Isoform 2 Prevalence and Prognostic Association in Gastric and Gastroesophageal Junction Adenocarcinoma. JCO precision oncology 8 (2024)
Kohei Shitara, Manish A Shah, Florian Lordick, Eric Van Cutsem, David H Ilson, Samuel J Klempner, Yoon-Koo Kang, Sara Lonardi, Yi-Ping Hung, Kensei Yamaguchi, Peter Enzinger, Tomoko Nakajima, Maria Matsangou, Ying Cao, Ran Li, Diarmuid Moran, Rupesh Pophale, Mok Oh, Radhika Ranganath, Jaffer A Ajani, Rui-Hua Xu
Zolbetuximab in Gastric or Gastroesophageal Junction Adenocarcinoma. The New England journal of medicine (2024)
Juhyung Park, Jibo Wu, Krzysztof J Szkop, Jinho Jeong, Predrag Jovanovic, Dylan Husmann, Natasha M Flores, Joel W Francis, Ying-Jiun C Chen, Ana Morales Benitez, Emily Zahn, Shumei Song, Jaffer A Ajani, Linghua Wang, Kamini Singh, Ola Larsson, Benjamin A Garcia, Ivan Topisirovic, Or Gozani, Pawel K Mazur
SMYD5 methylation of rpL40 links ribosomal output to gastric cancer. Nature (2024)
Timothy P DiPeri, Kathleen Kong, Kaushik Varadarajan, Daniel D Karp, Jaffer A Ajani, Shubham Pant, Michael F Press, Sarina A Piha-Paul, Ecaterina E Ileana Dumbrava, Funda Meric-Bernstam
Discordance of HER2 Expression and/or Amplification on Repeat Testing. Molecular cancer therapeutics (2023)
Timothy P DiPeri, Kurt W Evans, Maria Gabriela Raso, Ming Zhao, Yasmeen Q Rizvi, Xiaofeng Zheng, Bailiang Wang, Bryce P Kirby, Kathleen Kong, Michael Kahle, Timothy Anthony Yap, Ecaterina E Ileana Dumbrava, Jaffer A Ajani, Siqing Fu, Khandan Keyomarsi, Funda Meric-Bernstam
Adavosertib Enhances Antitumor Activity of Trastuzumab Deruxtecan in HER2-Expressing Cancers. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Yibo Fan, Shumei Song, Yuan Li, Shilpa S Dhar, Jiankang Jin, Katsuhiro Yoshimura, Xiaodan Yao, Ruiping Wang, Ailing W Scott, Melissa P Pizzi, JingJing Wu, Lang Ma, George Adrian Calin, Samir M Hanash, Linghua Wang, Michael A Curran, Jaffer A Ajani
Galectin-3 Cooperates with CD47 to Suppress Phagocytosis and T cell Immunity in Gastric Cancer Peritoneal Metastases. Cancer research (2023)
Yanshuo Chu, Enyu Dai, Yating Li, Guangchun Han, Guangsheng Pei, Davis R Ingram, Krupa Thakkar, Jiang-Jiang Qin, Minghao Dang, Xiuning Li, Can Hu, Qing Deng, Ansam Sinjab, Pravesh Gupta, Ruiping Wang, Dapeng Hao, Fuduan Peng, Xinmiao Yan, Yunhe Liu, Shumei Song, Shaojun Zhang, John Victor Heymach, Alexandre Reuben, Yasir Y Elamin, Melissa P Pizzi, Yang Lu, Rossana Lazcano, Jian Hu, Mingyao Li, Michael A Curran, P Andrew Futreal, Anirban Maitra, Amir A Jazaeri, Jaffer A Ajani, Charles Swanton, Xiang-Dong Cheng, Hussein A Abbas, Maura Gillison, Krishna P Bhat, Alexander J F Lazar, Michael R Green, Kevin Litchfield, Humam Kadara, Cassian Yee, Linghua Wang
Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance. Nature medicine (2023)
Manish A Shah, Kohei Shitara, Jaffer A Ajani, Yung-Jue Bang, Peter Enzinger, David Ilson, Florian Lordick, Eric Van Cutsem, Javier Gallego Plazas, Jing Huang, Lin Shen, Sang Cheul Oh, Patrapim Sunpaweravong, Hwoei Fen Soo Hoo, Haci Mehmet Turk, Mok Oh, Jung Wook Park, Diarmuid Moran, Pranob Bhattacharya, Ahsan Arozullah, Rui-Hua Xu
Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: the randomized, phase 3 GLOW trial. Nature medicine (2023)
Yuki Hirata, Ayesha Noorani, Shumei Song, Linghua Wang, Jaffer A Ajani
Early stage gastric adenocarcinoma: clinical and molecular landscapes. Nature reviews. Clinical oncology (2023)
Yuichiro Doki, Jaffer A Ajani, Ken Kato, Jianming Xu, Lucjan Wyrwicz, Satoru Motoyama, Takashi Ogata, Hisato Kawakami, Chih-Hung Hsu, Antoine Adenis, Farid El Hajbi, Maria Di Bartolomeo, Maria I Braghiroli, Eva Holtved, Sandra A Ostoich, Hye R Kim, Masaki Ueno, Wasat Mansoor, Wen-Chi Yang, Tianshu Liu, John Bridgewater, Tomoki Makino, Ioannis Xynos, Xuan Liu, Ming Lei, Kaoru Kondo, Apurva Patel, Joseph Gricar, Ian Chau, Yuko Kitagawa, null null
Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma. The New England journal of medicine 386 (5) (2022)
Sun Young Rha, Geoffrey Y Ku, Hyo Song Kim, Hyun Cheol Chung, Fatemeh Ghazanfari Amlashi, Dipen Maheshbhai Maru, Carly A Fein, Laura H Tang, Wei Zhou, Ting Wu, Senaka A Peter, David P Kelsen, Jaffer A Ajani
PD-L1 expression and overall survival in Asian and western patients with gastric cancer. Future oncology (London, England) 18 (21) (2022)
Kohei Shitara, Jaffer A Ajani, Markus Moehler, Marcelo Garrido, Carlos Gallardo, Lin Shen, Kensei Yamaguchi, Lucjan Wyrwicz, Tomasz Skoczylas, Arinilda Campos Bragagnoli, Tianshu Liu, Mustapha Tehfe, Elena Elimova, Ricardo Bruges, Thomas Zander, Sergio de Azevedo, Ruben Kowalyszyn, Roberto A Pazo-Cid, Michael Schenker, James M Cleary, Patricio Yanez, Kynan Feeney, Michalis V Karamouzis, Valerie Poulart, Ming Lei, Hong Xiao, Kaoru Kondo, Mingshun Li, Yelena Y Janjigian
Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancer. Nature 603 (7903) (2022)
Julius Weng, Jaffer A Ajani, Mariela Blum Murphy, Brian D Badgwell, Amanda S Tchakarov, Omar Mamlouk, Prajnan Das
Immunotherapy Recall: Chemoradiation-Induced Reactivation of Immune Checkpoint Inhibitor Nephritis. JCO precision oncology 6 (2022)
Salma K Jabbour, Terence M Williams, Mutlay Sayan, Eric D Miller, Jaffer A Ajani, Andrew C Chang, Norman Coleman, Wael El-Rifai, Michael Haddock, David Ilson, Daniel Sabido Jamorabo, Charles Kunos, Steven Lin, Geoffrey Liu, Pataje G Prasanna, Anil K Rustgi, Rosemary Wong, Bhadrasain Vikram, Mansoor M Ahmed
Potential Molecular Targets in the Setting of Chemoradiation for Esophageal Malignancies. Journal of the National Cancer Institute 113 (6) (2022)
Henry Hiep Vo, Siqing Fu, David S Hong, Daniel D Karp, Sarina Piha-Paul, Vivek Subbiah, Filip Janku, Aung Naing, Timothy A Yap, Jordi Rodon, Jaffer A Ajani, Carrie Cartwright, Amber M Johnson, I-Wen Song, Jennifer Beck, Michael Kahle, Graciela M Nogueras-Gonzalez, Vincent Miller, Calvin Chao, David J Vining, Donald A Berry, Funda Meric-Bernstam, Apostolia-Maria Tsimberidou
Challenges and opportunities associated with the MD Anderson IMPACT2 randomized study in precision oncology. NPJ precision oncology 6 (1) (2022)
Filip Janku, Sae-Won Han, Toshihiko Doi, Alessio Amatu, Jaffer A Ajani, Yasutoshi Kuboki, Alex Cortez, Susan E Cellitti, Ping C Mahling, Kulandayan Subramanian, Heidi A Schoenfeld, Sarah M Choi, Lori A Iaconis, Lang Ho Lee, Marc R Pelletier, Glenn Dranoff, Vasileios Askoxylakis, Salvatore Siena
Preclinical Characterization and Phase I Study of an Anti-HER2-TLR7 Immune-Stimulator Antibody Conjugate in Patients with HER2+ Malignancies. Cancer immunology research 10 (12) (2022)
Yuan Li, Yibo Fan, Jinbang Xu, Longfei Huo, Ailing W Scott, Jiankang Jin, Boxuan Yang, Shan Shao, Lang Ma, Ying Wang, Xiaodan Yao, Melissa Pool Pizzi, Matheus Sewastjanow Da Silva, Guoliang Zhang, Lijuan Zhuo, Eun Jeong Cho, Kevin N Dalby, Namita D Shanbhag, Zhenning Wang, Wenliang Li, Shumei Song, Jaffer A Ajani
GRK3 is a poor prognosticator and serves as a therapeutic target in advanced gastric adenocarcinoma. Journal of experimental & clinical cancer research : CR 41 (1) (2022)
Amir Mehrvarz Sarshekeh, Jumanah Alshenaifi, Jason Roszik, Ganiraju C Manyam, Shailesh M Advani, Riham Katkhuda, Anuj Verma, Michael Lam, Jason Willis, John Paul Shen, Jeffrey Morris, Jennifer S Davis, Jonathan M Loree, Hey Min Lee, Jaffer A Ajani, Dipen Maheshbhai Maru, Michael James Overman, Scott Kopetz
ARID1A Mutation May Define an Immunologically Active Subgroup in Patients with Microsatellite Stable Colorectal Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (6) (2021)
Shumei Song, Yan Xu, Longfei Huo, Shuangtao Zhao, Ruiping Wang, Yuan Li, Ailing W Scott, Melissa Pool Pizzi, Ying Wang, Yibo Fan, Kazuto Harada, Jiankang Jin, Lang Ma, Xiaodan Yao, Namita D Shanbhag, Qiong Gan, Sinchita Roy-Chowdhuri, Brian D Badgwell, Zhenning Wang, Linghua Wang, Jaffer A Ajani
Patient-derived cell lines and orthotopic mouse model of peritoneal carcinomatosis recapitulate molecular and phenotypic features of human gastric adenocarcinoma. Journal of experimental & clinical cancer research : CR 40 (1) (2021)
Manish A Shah, Gyorgy Bodoky, Alexander Starodub, David Cunningham, Desmond Yip, Zev A Wainberg, Johanna Bendell, Dung Thai, Joyce He, Pankaj Bhargava, Jaffer A Ajani
Phase III Study to Evaluate Efficacy and Safety of Andecaliximab With mFOLFOX6 as First-Line Treatment in Patients With Advanced Gastric or GEJ Adenocarcinoma (GAMMA-1). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (9) (2021)
Shumei Song, Qiongrong Chen, Yuan Li, Guang Lei, Ailing Scott, Longfei Huo, Cordelia Y Li, Jeannelyn Santiano Estrella, Arlene Correa, Melissa Pool Pizzi, Lang Ma, Jiankang Jin, Bin Liu, Ying Wang, Lianchun Xiao, Wayne L Hofstetter, Jeffrey H Lee, Brian Weston, Manoop Bhutani, Namita Shanbhag, Randy L Johnson, Boyi Gan, Shaozhong Wei, Jaffer A Ajani
Targeting cancer stem cells with a pan-BCL-2 inhibitor in preclinical and clinical settings in patients with gastroesophageal carcinoma. Gut 70 (12) (2021)
Xiaochuan Dong, Shumei Song, Yuan Li, Yibo Fan, Lulu Wang, Ruiping Wang, Longfei Huo, Ailing Scott, Yan Xu, Melissa Pool Pizzi, Lang Ma, Ying Wang, Jiangkang Jin, Wei Zhao, Xiaodan Yao, Randy L Johnson, Linghua Wang, Zhen-Ning Wang, Guang Peng, Jaffer A Ajani
Loss of ARID1A activates mTOR signaling and SOX9 in gastric adenocarcinoma-rationale for targeting ARID1A deficiency. Gut (2021)
Ronan J Kelly, Jaffer A Ajani, Jaroslaw Kuzdzal, Thomas Zander, Eric Van Cutsem, Guillaume Piessen, Guillermo Mendez, Josephine Feliciano, Satoru Motoyama, Astrid Lièvre, Hope Uronis, Elena Elimova, Cecile Grootscholten, Karen Geboes, Syed Zafar, Stephanie Snow, Andrew H Ko, Kynan Feeney, Michael Schenker, Piotr Kocon, Jenny Zhang, Lili Zhu, Ming Lei, Prianka Singh, Kaoru Kondo, James M Cleary, Markus Moehler, null null
Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer. The New England journal of medicine 384 (13) (2021)
Ruiping Wang, Minghao Dang, Kazuto Harada, Guangchun Han, Fang Wang, Melissa Pool Pizzi, Meina Zhao, Ghia Tatlonghari, Shaojun Zhang, Dapeng Hao, Yang Lu, Shuangtao Zhao, Brian D Badgwell, Mariela Blum Murphy, Namita Shanbhag, Jeannelyn S Estrella, Sinchita Roy-Chowdhuri, Ahmed Adel Fouad Abdelhakeem, Yuanxin Wang, Guang Peng, Samir M Hanash, George Adrian Calin, Xingzhi Song, Yanshuo Chu, Jianhua Zhang, Mingyao Li, Ken Chen, Alexander J F Lazar, P Andrew Futreal, Shumei Song, Jaffer A Ajani, Linghua Wang
Single-cell dissection of intratumoral heterogeneity and lineage diversity in metastatic gastric adenocarcinoma. Nature medicine 27 (1) (2021)
Guangchun Han, Guoliang Yang, Dapeng Hao, Yang Lu, Kyaw Zin Thein, Benjamin Scott S Simpson, Jianfeng Chen, Ryan Sun, Omar Alhalabi, Ruiping Wang, Minghao Dang, Enyu Dai, Shaojun Zhang, Fengqi Nie, Shuangtao Zhao, Charles Guo, Ameer Hamza, Bogdan Czerniak, Chao Cheng, Arlene Siefker-Radtke, Krishna P Bhat, P Andrew Futreal, Guang Peng, Jennifer A Wargo, Weiyi Peng, Humam Kadara, Jaffer A Ajani, Charles Swanton, Kevin Litchfield, Jordi Rodon Ahnert, Jianjun Gao, Linghua Wang
9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapy. Nature communications 12 (1) (2021)
Mihnea Paul Dragomir, Edmund S Kopetz, Jaffer A Ajani, George Adrian Calin
Non-coding RNAs in GI cancers: from cancer hallmarks to clinical utility. Gut 69 (4) (2020)
Jaffer A Ajani, Yan Xu, Longfei Huo, Ruiping Wang, Yuan Li, Ying Wang, Melissa Pool Pizzi, Ailing Scott, Kazuto Harada, Lang Ma, Xiaodan Yao, Jiankang Jin, Wei Zhao, Xiaochuan Dong, Brian D Badgwell, Namita Shanbhag, Ghia Tatlonghari, Jeannelyn Santiano Estrella, Sinchita Roy-Chowdhuri, Makoto Kobayashi, Jody V Vykoukal, Samir M Hanash, George Adrian Calin, Guang Peng, Ju-Seog Lee, Randy L Johnson, Zhenning Wang, Linghua Wang, Shumei Song
YAP1 mediates gastric adenocarcinoma peritoneal metastases that are attenuated by YAP1 inhibition. Gut 70 (1) (2020)
Yang Liu, Yoshifumi Baba, Takatsugu Ishimoto, Hiroyasu Tsutsuki, Tianli Zhang, Daichi Nomoto, Kazuo Okadome, Kensuke Yamamura, Kazuto Harada, Kojiro Eto, Yukiharu Hiyoshi, Masaaki Iwatsuki, Yohei Nagai, Shiro Iwagami, Yuji Miyamoto, Naoya Yoshida, Yoshihiro Komohara, Masaki Ohmuraya, Xiaoming Wang, Jaffer A Ajani, Tomohiro Sawa, Hideo Baba
Fusobacterium nucleatum confers chemoresistance by modulating autophagy in oesophageal squamous cell carcinoma. British journal of cancer 124 (5) (2020)
Dapeng Hao, Siyuan He, Kazuto Harada, Melissa Pool Pizzi, Yang Lu, Pujun Guan, Lu Chen, Ruiping Wang, Shaojun Zhang, Matheus Sewastjanow-Silva, Ahmed Abdelhakeem, Namita Shanbhag, Manoop Bhutani, Guangchun Han, Jeffrey H Lee, Shuangtao Zhao, Brian Weston, Mariela Blum Murphy, Rebecca Waters, Jeannelyn Santiano Estrella, Sinchita Roy-Chowdhuri, Qiong Gan, Ju-Seog Lee, Guang Peng, Samir M Hanash, George Adrian Calin, Xingzhi Song, Jianhua Zhang, Shumei Song, Linghua Wang, Jaffer A Ajani
Integrated genomic profiling and modelling for risk stratification in patients with advanced oesophagogastric adenocarcinoma. Gut 70 (11) (2020)
Kohei Yamashita, Masaaki Iwatsuki, Noriko Yasuda-Yoshihara, Takeshi Morinaga, Yosuke Nakao, Kazuto Harada, Kojiro Eto, Junji Kurashige, Yukiharu Hiyoshi, Takatsugu Ishimoto, Yohei Nagai, Shiro Iwagami, Yoshifumi Baba, Yuji Miyamoto, Naoya Yoshida, Jaffer A Ajani, Hideo Baba
Trastuzumab upregulates programmed death ligand-1 expression through interaction with NK cells in gastric cancer. British journal of cancer 124 (3) (2020)
Kazuto Harada, Hyunsoo Hwang, Xuemei Wang, Ahmed Abdelhakeem, Masaaki Iwatsuki, Mariela A Blum Murphy, Dipen M Maru, Brian Weston, Jeffrey H Lee, Jane E Rogers, Allison Trail, Namita Shanbhag, Meina Zhao, Manoop S Bhutani, Quynh-Nhu Nguyen, Stephen G Swisher, Naruhiko Ikoma, Prajnan Das, Wayne L Hofstetter, Brian D Badgwell, Jaffer A Ajani
Brain metastases in patients with upper gastrointestinal cancer is associated with proximally located adenocarcinoma and lymph node metastases. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 23 (5) (2020)
Tomoyuki Uchihara, Keisuke Miyake, Atsuko Yonemura, Yoshihiro Komohara, Rumi Itoyama, Mayu Koiwa, Tadahito Yasuda, Kota Arima, Kazuto Harada, Kojiro Eto, Hiromitsu Hayashi, Masaaki Iwatsuki, Shiro Iwagami, Yoshifumi Baba, Naoya Yoshida, Masakazu Yashiro, Mari Masuda, Jaffer A Ajani, Patrick Tan, Hideo Baba, Takatsugu Ishimoto
Extracellular Vesicles from Cancer-Associated Fibroblasts Containing Annexin A6 Induces FAK-YAP Activation by Stabilizing β1 Integrin, Enhancing Drug Resistance. Cancer research 80 (16) (2020)
Fang He, Huai-Qiang Ju, Yi Ding, Zhiqiang Jiang, Zhenhui Li, Bo Huang, Xiu-Hong Wang, Yuanyuan Zhao, Yong Li, Bin Qi, Wenguang Luo, Zijian Zhang, Qian Pei, Haiyang Chen, Shuai Liu, Xiaolin Chen, Jian Zheng, Jianping Wang, Jaffer A Ajani, Xiang-Bo Wan
Association between adjuvant chemotherapy and survival in patients with rectal cancer and pathological complete response after neoadjuvant chemoradiotherapy and resection. British journal of cancer 123 (8) (2020)
Stefano Cascinu, György Bodoky, Kei Muro, Eric Van Cutsem, Sang Cheul Oh, Gunnar Folprecht, Sumitra Ananda, Gustavo Girotto, Zev A Wainberg, Maria Luisa Limon Miron, Jaffer A Ajani, Ran Wei, Astra M Liepa, Roberto Carlesi, Michael Emig, Atsushi Ohtsu
Tumor Response and Symptom Palliation from RAINBOW, a Phase III Trial of Ramucirumab Plus Paclitaxel in Previously Treated Advanced Gastric Cancer. The oncologist 26 (3) (2020)
Shumei Song, Zhenning Wang, Yuan Li, Lang Ma, Jiankang Jin, Ailing W Scott, Yan Xu, Jeannelyn Santiano Estrella, Yongxi Song, Bin Liu, Randy L Johnson, Jaffer A Ajani
PPARδ Interacts with the Hippo Coactivator YAP1 to Promote SOX9 Expression and Gastric Cancer Progression. Molecular cancer research : MCR 18 (3) (2019)
Naruhiko Ikoma, Janice N Cormier, Barry W Feig, Xianglin L Du, Jose-Miguel Yamal, Wayne Hofstetter, Prajnan Das, Jaffer A Ajani, Christina L Roland, Keith Fournier, Richard Royal, Paul Mansfield, Brian D Badgwell
Racial disparities in preoperative chemotherapy use in gastric cancer patients in the United States: Analysis of the National Cancer Data Base, 2006-2014. Cancer 124 (5) (2018)
Mariela Blum Murphy, Lianchum Xiao, Viren R Patel, Dipen M Maru, Arlene M Correa, Fatemeh Ghazanfari Amlashi, Zhongxing Liao, Ritsuko Komaki, Steven Hsesheng Lin, Heath D Skinner, Ara Vaporciyan, Garrett L Walsh, Stephen G Swisher, Boris Sepesi, Jeffrey H Lee, Manoop S Bhutani, Brian Weston, Wayne L Hofstetter, Jaffer A Ajani
Pathological complete response in patients with esophageal cancer after the trimodality approach: The association with baseline variables and survival-The University of Texas MD Anderson Cancer Center experience. Cancer 123 (21) (2017)

Jaffer A Ajani (Jaffer Ajani)

Publication Activity (10 Years)

Top Topics

Top Venues